Androgens and progesterone are tested together due to their proximity to each other on the hormone cascade. The Androgens and Progesterones Profile combines unconjugated steroid hormones and their metabolites, providing insight into the efficiency of the enzymes that metabolize them. This non-invasive test requires only 4 or 5 separate urine collections. This profile is a consideration for baseline or follow up testing for patients with concerns that are particular to androgens and progesterones and/or monitoring for harmful metabolites due to the influence of HRT/BHRT. Patient FAQs and Best Practices for HuMap
5 to 7 days
Note: Turnaround times on results are an estimate and are not guaranteed. The lab may need additional time due to holidays, confirmation/repeat testing, etc. You can contact us to discuss when your results should be ready.
Click any analyte name for additional clinical information, including reference ranges, specimen collection, stability and rejection criteria.
List price applies when filing with insurance or Medicare, or when billing a patient directly. Prompt payment pricing applies when billing to a physician account or prepayment is received with the test.
Doctor's Data offers profiles containing multiple analytes. *Multiple analytes may be billed under a single CPT code. Many analytes can be ordered individually. Pricing may vary. Click on a specific analyte for more information or read our detailed billing and payment policies.
The CPT codes listed on our website are for informational purposes only. This information is our interpretation of CPT coding requirements and may not necessarily be correct. You are advised to consult the CPT Coding Manual published by the American Medical Association. Doctor's Data, Inc. takes no responsibility for billing errors due to your use of any CPT information from our website.
Sign in at the top of any page to view pricing and order tests. Or click here to create an account. You may also contact us for assistance placing an order.
Progesterones:
Progesterone (P4) is primarily produced in the corpus luteum following ovulation in women, and to a lesser degree in the adrenal glands in both sexes. In urine, progesterone is a clinical marker of luteal activity and therapeutic oral progesterone administration. The most important progesterone metabolite, pregnanediol (PD), is a marker of endogenous progesterone levels and an indicator of ovulation. PD exists as two isomers, 5α-pregnanediol (5A-PD), and 5β-pregnanediol (5B-PD). 5B-PD represents the majority endpoint of endogenous progesterone metabolism and appears to have little physiological activity, while 5A-PD, the lesser metabolite of PDL, can cross the blood-brain barrier and has been shown to partially agonize GABA-A receptors, perhaps due to its role as an immediate precursor to allopregnanolone. Allopregnanolone (ALLOP) is a potent neuroactive steroid capable of binding the GABA-A receptor contributing to a sedative and anxiolytic effect. This calming action is seen with orally supplemented progesterone, as it is metabolized to neuroactive steroid ALLOP in the liver.
Androgens:
Androgens play a significant role in structure and function of muscle, bone, and connective tissue, metabolic homeostasis and reproduction in both men and women. When evaluating the androgens, it is important to assess unconjugated hormones, enzymes, metabolites, and clinical symptoms to gain an understanding of the complete clinical picture. The key areas of focus within the androgen pathway are androstenedione, DHEA, testosterone, 5-alpha and 5-beta reductase. Testosterone is derived from androstenedione and DHEA. 5α-reductase converts testosterone into the metabolite 5α-DHT which is three times more potent than testosterone. Symptoms associated with higher androgen levels (thinning hair, acne, etc) are often seen when levels of 5α-reductase and its corresponding metabolites are elevated. 5b-reductase and its corresponding metabolites are much less androgenic. The assessment of 5 alpha and 5 beta metabolisms can be understood by following the metabolism of androstenedione to etiocholanolone (5α) and androstenedione to androsterone (5β). The relative ratio between these two pathways and the amounts of 5α androstanediol and 5β-androstanediol may give insight into the full androgenic picture. Androgen deficiency symptoms can be caused by lower levels of DHEA, testosterone, or 5α metabolites.
